COVID-19 mRNA vaccines teach the immune formula to recognize and fight the coronavirus, reducing the threat of serious illness if a user is infected. .
More than a billion doses of COVID-19 vaccines have already been administered in the United States and only very few protection issues have arisen. The vast majority of people delight in only transient side effects, such as injection pain, fatigue, headaches or muscle aches, or no aspect effects. As the Centers for Disease Control and Prevention stated, those vaccines “have passed and will continue to go through the highest extensive protective oversight in the history of the United States. “
A small number of severe allergic reactions known as anaphylaxis, which are expected with any vaccine, have occurred with licensed and approved COVID-19 vaccines. Fortunately, such reactions are rare, occur within minutes of inoculation, and can be treated. According to the CDC, approximately five out of every million vaccinated people have experienced anaphylaxis after a COVID-19 vaccine.
To ensure that severe allergic reactions can be detected and treated, all other people receiving a vaccine will be observed for 15 minutes after being vaccinated, and anyone who has suffered anaphylaxis or had an immediate allergic reaction to a vaccine or injection in the past. be monitored for part of an hour. People who have had a severe allergic reaction to a previous dose or to any of the ingredients in the vaccine will not be immunized. In addition, those who do not get one type of COVID-19 vaccine will be monitored for 30 minutes after receiving some other type. of vaccine
Pfizer/BioNTech and Moderna mRNA vaccines rarely cause inflammation of the central muscle (myocarditis) or surrounding mucosa (pericarditis), especially in adolescents and young adult males.
According to knowledge collected through August 2021, notification rates for any of the conditions in the United States are highest among men older than 16 to 17 years after the current dose (105. 9 instances consistent with millions of doses of the Pfizer/BioNTech vaccine), followed by 12 to 15 years of male (70. 7 cases equivalent to millions). The rate in older men aged 18 to 24 years 52. 4 cases and 56. 3 cases equivalent to millions of doses of Pfizer/BioNTech and Moderna vaccines, respectively.
Health officials have noted that vaccine-related cases of myocarditis and pericarditis are rare and that the benefits of vaccination outweigh the risks. Preliminary evidence suggests that those cases of myocarditis are less severe than typical cases. The CDC also noted that most of the treated patients “responded well to medicine and rest and felt better quickly. “
The Johnson Vaccine
According to the CDC, TTS occurred in about four more people based on millions of doses administered. In early April, the syndrome appeared in 60 cases, adding up to nine deaths, after more than 18. 6 million doses of the J vaccine.
Vaccine J
link to this
Q. Are other vaccinated and vaccinated people more likely to become inflamed or have the omicron variant than other unvaccinated people?
R. No. Getting vaccinated increases your coverage against COVID-19. Sometimes some unprepared knowledge would recommend otherwise, but this data cannot be used to determine the efficacy of a vaccine.